What Challenges Exist for 3D Printed Medications in Pediatrics?
While promising, 3D printed medications face several challenges in pediatric applications. One major hurdle is the scalability of production. Currently, 3D printing technology is more suited to small-batch production rather than mass production, which may limit its use in widespread healthcare settings.
Another challenge is the cost associated with 3D printing. The technology requires significant investment in equipment, materials, and training, which can be prohibitive for some healthcare institutions. Moreover, regulatory pathways for 3D printed drugs are still being developed, which can delay their availability.
